175 related articles for article (PubMed ID: 14677066)
21. Expression of p16 protein and cyclin D1 in periampullary carcinomas.
Tuncer E; Türk NS; Arici S; Düzcan SE; Demirkan NC
Turk Patoloji Derg; 2011 Jan; 27(1):17-22. PubMed ID: 21469422
[TBL] [Abstract][Full Text] [Related]
22. Signet ring cell adenocarcinoma of the ampulla of Vater: a rare pathology.
Lesquereux-Martínez L; Fernández-Pérez A; Bustamante-Montalvo M
Rev Esp Enferm Dig; 2012 Sep; 104(9):501-2. PubMed ID: 23130863
[No Abstract] [Full Text] [Related]
23. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization.
Chang MC; Chang YT; Tien YW; Sun CT; Wu MS; Lin JT
Oncol Rep; 2005 Oct; 14(4):867-72. PubMed ID: 16142344
[TBL] [Abstract][Full Text] [Related]
24. Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Kang SP; Saif MW
JOP; 2011 Mar; 12(2):123-5. PubMed ID: 21386636
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the P16-binding domain of cyclin-dependent kinase 4 in tumors in the head region of the pancreas.
Ceha HM; Clement MJ; Polak MM; Offerhaus GJ; Slebos RJ
Pancreas; 1998 Jul; 17(1):85-8. PubMed ID: 9667525
[TBL] [Abstract][Full Text] [Related]
26. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.
Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Kijima H; Saito T
Cancer; 1999 Aug; 86(4):596-607. PubMed ID: 10440687
[TBL] [Abstract][Full Text] [Related]
27. Analysis of K-ras gene mutations in rare pancreatic and ampullary tumours.
Ebert MP; Hoffmann J; Schneider-Stock R; Kasper HU; Schulz HU; Lippert H; Roessner A; Malfertheiner P
Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1025-9. PubMed ID: 9895049
[TBL] [Abstract][Full Text] [Related]
28. 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells.
Halloran CM; Ghaneh P; Shore S; Greenhalf W; Zumstein L; Wilson D; Neoptolemos JP; Costello E
J Gene Med; 2004 May; 6(5):514-25. PubMed ID: 15133762
[TBL] [Abstract][Full Text] [Related]
29. Biological and molecular characterization of a new human ampullary cancer cell line.
Peiper M; Alldinger I; Heller R; Pilarsky C; Schumacher U; Knoefel WT; Heinecke A; Izbicki JR
Anticancer Res; 2003; 23(1A):291-8. PubMed ID: 12680226
[TBL] [Abstract][Full Text] [Related]
30. K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis.
Wenger FA; Zieren J; Peter FJ; Jacobi CA; Müller JM
Langenbecks Arch Surg; 1999 Apr; 384(2):181-6. PubMed ID: 10328172
[TBL] [Abstract][Full Text] [Related]
31. Ampulla of vater adenocarcinoma in a BRCA2 germline mutation carrier.
Aburjania N; Truskinovsky AM; Overman MJ; Lou E
J Gastrointest Cancer; 2014 Mar; 45(1):87-90. PubMed ID: 23417715
[No Abstract] [Full Text] [Related]
32. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
[TBL] [Abstract][Full Text] [Related]
33. An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine.
Bhattacharyya M; Francis J; Eddouadi A; Lemoine NR; Halldén G
Cancer Gene Ther; 2011 Oct; 18(10):734-43. PubMed ID: 21836633
[TBL] [Abstract][Full Text] [Related]
34. ras-family gene mutations in neoplasia of the ampulla of Vater.
Scarpa A; Zamboni G; Achille A; Capelli P; Bogina G; Iacono C; Serio G; Accolla RS
Int J Cancer; 1994 Oct; 59(1):39-42. PubMed ID: 7927901
[TBL] [Abstract][Full Text] [Related]
35. Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations.
Mafficini A; Amato E; Cataldo I; Rusev BC; Bertoncello L; Corbo V; Simbolo M; Luchini C; Fassan M; Cantù C; Salvia R; Marchegiani G; Tortora G; Lawlor RT; Bassi C; Scarpa A
Ann Surg; 2018 Jan; 267(1):149-156. PubMed ID: 27611608
[TBL] [Abstract][Full Text] [Related]
36. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S
Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
[TBL] [Abstract][Full Text] [Related]
37. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
[TBL] [Abstract][Full Text] [Related]
38. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene.
Motojima K; Tsunoda T; Kanematsu T; Nagata Y; Urano T; Shiku H
Ann Surg; 1991 Dec; 214(6):657-62. PubMed ID: 1741644
[TBL] [Abstract][Full Text] [Related]
39. Involvement of 1p36 region in two cases of adenocarcinoma of the ampulla of Vater.
Bernasconi B; Dossena B; Billo PR; Tibiletti MG; Sessa F
Cancer Genet Cytogenet; 2002 Oct; 138(2):133-8. PubMed ID: 12505258
[TBL] [Abstract][Full Text] [Related]
40. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
